Cerenovus, Part of DePuy Synthes Products
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Cerenovus, Part of DePuy Synthes Products sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
Cerenovus, Part of DePuy Synthes Products: 5 sponsored US clinical trials, 1 recruiting.
Cerenovus, Part of DePuy Synthes Products sponsors 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 3 completed. The most-studied condition in this pipeline is Aneurysms, with 1 trials.
Upper-quartile sponsor footprint
Cerenovus, Part of DePuy Synthes Products sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
5 total, page 1 of 1
MMA Embolization for Refractory Chronic Migraine
NCT06735833
Middle Meningeal Artery Embolization for the Treatment of Subdural Hematomas With TRUFILL® n-BCA
NCT04816591
CERENOVUS Neurothrombectomy Devices Registry
NCT03685578
A Study to Look at Performance of MICRUSFRAME and GALAXY Coils for the Treatment of Intracranial Aneurysms
NCT03642639
Study to Evaluate the Safety and Effectiveness of the CODMAN ENTERPRISE® Vascular Reconstruction Device
NCT02532517
What is open in the Cerenovus, Part of DePuy Synthes Products pipeline
1 recruiting of 5 indexed (20% open); 3 completed (60%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Aneurysms (1 trial), 1 other listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Cerenovus, Part of DePuy Synthes Products: open-pipeline peers nationwide
Peers matched on 5 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
Cerenovus, Part of DePuy Synthes Products sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 trials (± recruiting share)
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors near 20% open enrollment (± trial volume)
- Align Technology · 20% recruiting · 5 trials
- AltruBio · 20% recruiting · 5 trials
- Alvernia University · 20% recruiting · 5 trials
- Amazentis · 20% recruiting · 5 trials
Related
What to do with this Cerenovus, Part of DePuy Synthes Products page
5 registered trials is a research-attention snapshot, not an endorsement of Cerenovus, Part of DePuy Synthes Products or any single study.
- 1 of Cerenovus, Part of DePuy Synthes Products's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Aneurysms is the condition Cerenovus, Part of DePuy Synthes Products studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Aneurysms trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Cerenovus, Part of DePuy Synthes Products pipeline card: 5 registered trials from official public datasets.Report a data error.